Advaxis - Stock Price History | ADXS

Historical daily share price chart and data for Advaxis since 2020 adjusted for splits. The latest closing stock price for Advaxis as of May 22, 2020 is 0.71.
  • The all-time high Advaxis stock closing price was 62.50 on July 29, 2005.
  • The Advaxis 52-week high stock price is 2.95, which is 315.5% above the current share price.
  • The Advaxis 52-week low stock price is 0.21, which is 70.4% below the current share price.
  • The average Advaxis stock price for the last 52 weeks is 0.83.
Advaxis Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.1949 0.2950 6.5100 0.2485 0.8577 351.42%
2018 1.4992 3.1000 3.2400 0.1855 0.1900 -93.31%
2017 6.4869 7.4900 9.6000 2.8200 2.8400 -60.34%
2016 8.9600 9.4100 15.9800 5.4600 7.1600 -28.83%
2015 14.7490 8.4200 28.7700 7.0200 10.0600 25.59%
2014 3.6215 4.0800 9.0000 2.5100 8.0100 88.92%
2013 6.5045 3.7500 17.5000 2.7000 4.2400 13.07%
2012 11.6800 20.0000 21.2500 3.7500 3.7500 -81.25%
2011 18.6210 15.0000 30.0000 15.0000 20.0000 33.33%
2010 19.6726 16.2500 28.7500 12.5000 15.0000 -14.29%
2009 10.6448 2.5000 21.2500 2.5000 17.5000 600.00%
2008 10.1117 21.2500 21.2500 1.6250 2.5000 -88.24%
2007 28.6653 25.0000 53.7500 17.5000 21.2500 -5.56%
2006 27.1365 26.2500 37.5000 17.5000 22.5000 -14.29%
2005 30.7913 56.2500 62.5000 20.0000 26.2500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.043B $0.021B
Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence containing a tumor-specific antigen. The Company believes this vaccine technology is capable of stimulating the body's immune system to process and recognize the antigen as if it were foreign, generating an immune response able to attack the cancer. It also considers this to be a broadly enabling platform technology that can be applied to the treatment of many types of cancers, infectious diseases and auto-immune disorders. The Company's products in development include Lovaxin C and Lovaxin B, Lovaxin P.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.197B 14.66
Gilead Sciences (GILD) United States $91.996B 11.93
CSL (CSLLY) Australia $87.164B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.883B 50.79
Regeneron Pharmaceuticals (REGN) United States $62.700B 24.17
Illumina (ILMN) United States $52.141B 53.58
Biogen (BIIB) United States $49.695B 8.51
Seattle Genetics (SGEN) United States $26.964B 0.00
Moderna (MRNA) United States $25.614B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.414B 9.63
Incyte (INCY) United States $21.600B 0.00
Genmab (GMAB) Denmark $19.127B 15.75
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Genmab (GNMSF) Denmark $17.896B 53.13
BioMarin Pharmaceutical (BMRN) United States $17.633B 159.85
Alnylam Pharmaceuticals (ALNY) United States $16.134B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.977B 38.43
Exact Sciences (EXAS) United States $12.517B 0.00
BeiGene (BGNE) Cayman Islands $12.307B 0.00
Sarepta Therapeutics (SRPT) United States $11.745B 0.00
BioNTech SE (BNTX) Germany $11.546B 0.00
Bio-Techne Corp (TECH) United States $10.183B 67.27
QIAGEN (QGEN) Netherlands $9.791B 28.47
Horizon Therapeutics Public (HZNP) Ireland $9.455B 23.27
Guardant Health (GH) United States $9.166B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.986B 0.00
Immunomedics (IMMU) United States $7.959B 0.00
Exelixis (EXEL) United States $7.550B 26.47
Repligen (RGEN) United States $7.297B 127.99
Ascendis Pharma (ASND) Denmark $7.032B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.759B 0.00
Reata Pharmaceuticals (RETA) United States $5.318B 0.00
Acceleron Pharma (XLRN) United States $5.307B 0.00
Adaptive Biotechnologies (ADPT) United States $5.295B 0.00
MyoKardia (MYOK) United States $5.018B 0.00
Mirati Therapeutics (MRTX) United States $4.435B 0.00
Emergent Biosolutions (EBS) United States $4.435B 29.07
Ultragenyx Pharmaceutical (RARE) United States $4.403B 0.00
MorphoSys AG (MOR) Germany $4.291B 33.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.268B 93.25
China Biologic Products (CBPO) China $4.239B 23.57
Global Blood Therapeutics (GBT) United States $4.230B 0.00
Vir Biotechnology (VIR) United States $3.972B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.855B 0.00
Bluebird Bio (BLUE) United States $3.716B 0.00
Zai Lab (ZLAB) China $3.690B 0.00
Blueprint Medicines (BPMC) United States $3.532B 0.00
Halozyme Therapeutics (HALO) United States $3.341B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.309B 0.00
Amicus Therapeutics (FOLD) United States $3.267B 0.00
Viela Bio (VIE) United States $3.071B 0.00
NeoGenomics (NEO) United States $2.968B 216.77
Arena Pharmaceuticals (ARNA) United States $2.965B 0.00
UniQure (QURE) Netherlands $2.823B 0.00
Amarin (AMRN) Ireland $2.791B 0.00
Fate Therapeutics (FATE) United States $2.737B 0.00
Denali Therapeutics (DNLI) United States $2.688B 0.00
Alkermes (ALKS) Ireland $2.676B 52.69
Novavax (NVAX) United States $2.672B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.652B 0.00
Alector (ALEC) United States $2.616B 0.00
Insmed (INSM) United States $2.592B 0.00
Inovio Pharmaceuticals (INO) United States $2.226B 0.00
Principia Biopharma (PRNB) United States $2.148B 0.00
Epizyme (EPZM) United States $1.878B 0.00
Ligand Pharmaceuticals (LGND) United States $1.744B 67.90
Eidos Therapeutics (EIDX) United States $1.734B 0.00
Arvinas (ARVN) United States $1.724B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.707B 0.00
Editas Medicine (EDIT) United States $1.655B 0.00
Arcus Biosciences (RCUS) United States $1.648B 0.00
Zymeworks (ZYME) Canada $1.647B 0.00
Adverum Biotechnologies (ADVM) United States $1.644B 0.00
Sangamo Therapeutics (SGMO) United States $1.622B 0.00
REGENXBIO (RGNX) United States $1.618B 0.00
Twist Bioscience (TWST) United States $1.617B 0.00
Intra-Cellular Therapies (ITCI) United States $1.489B 0.00
Akcea Therapeutics (AKCA) United States $1.482B 0.00
Mesoblast (MESO) Australia $1.412B 0.00
PHARMA MAR SA (PHMMF) Spain $1.394B 0.00
NGM Biopharmaceuticals (NGM) United States $1.378B 0.00
Beam Therapeutics (BEAM) United States $1.319B 0.00
Cytokineticsorporated (CYTK) United States $1.303B 0.00
Zealand Pharma (ZEAL) Denmark $1.290B 0.00
I-Mab (IMAB) China $1.215B 0.00
Revance Therapeutics (RVNC) United States $1.212B 0.00
Coherus BioSciences (CHRS) United States $1.212B 8.46
Alcobra (ARCT) United States $1.159B 0.00
Myriad Genetics (MYGN) United States $1.098B 56.65
Intellia Therapeutics (NTLA) United States $1.078B 0.00
Sorrento Therapeutics (SRNE) United States $1.063B 0.00
Compugen (CGEN) Israel $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.939B 0.00
NextCure (NXTC) United States $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.907B 0.00
Cellectis S.A (CLLS) France $0.893B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Cue Biopharma (CUE) United States $0.856B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.773B 0.00
Cara Therapeutics (CARA) United States $0.770B 0.00
Heska (HSKA) United States $0.767B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.751B 0.00
Kadmon Holdings (KDMN) United States $0.746B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.724B 0.00
Retrophin (RTRX) United States $0.719B 0.00
Kala Pharmaceuticals (KALA) United States $0.714B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.700B 0.00
Codexis (CDXS) United States $0.662B 0.00
Castle Biosciences (CSTL) United States $0.653B 0.00
Vericel (VCEL) United States $0.643B 118.83
Morphic Holding (MORF) United States $0.640B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.625B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.620B 5.31
Bellus Health (BLU) Canada $0.620B 0.00
Frequency Therapeutics (FREQ) United States $0.612B 0.00
Athersys (ATHX) United States $0.601B 0.00
Mersana Therapeutics (MRSN) United States $0.584B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.578B 0.00
MeiraGTx Holdings (MGTX) United States $0.576B 0.00
VBI Vaccines (VBIV) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.555B 0.00
NantKwest (NK) United States $0.550B 0.00
AnaptysBio (ANAB) United States $0.542B 0.00
Clovis Oncology (CLVS) United States $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
UROGEN PHARMA (URGN) United States $0.531B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.521B 0.00
AC Immune SA (ACIU) Switzerland $0.503B 0.00
DBV Technologies S.A (DBVT) France $0.494B 0.00
BioDelivery Sciences (BDSI) United States $0.493B 25.97
Aquinox Pharmaceuticals (NLTX) United States $0.493B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Anika Therapeutics (ANIK) United States $0.474B 15.24
Dynavax Technologies (DVAX) United States $0.473B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.464B 0.00
Puma Biotechnology (PBYI) United States $0.461B 0.00
Merus (MRUS) Netherlands $0.440B 0.00
Intrexon (PGEN) United States $0.439B 0.00
Protagonist Therapeutics (PTGX) United States $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.430B 0.00
CytomX Therapeutics (CTMX) United States $0.426B 0.00
MiMedx (MDXG) United States $0.419B 0.00
Agenus (AGEN) United States $0.418B 0.00
Seres Therapeutics (MCRB) United States $0.401B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.396B 0.00
WAVE Life Sciences (WVE) Singapore $0.387B 0.00
PDL BioPharma (PDLI) United States $0.386B 331.00
Albireo Pharma (ALBO) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.382B 7.57
Kamada (KMDA) Israel $0.382B 15.89
Precision BioSciences (DTIL) United States $0.381B 0.00
Geron (GERN) United States $0.369B 0.00
Selecta Biosciences (SELB) United States $0.343B 0.00
MannKind (MNKD) United States $0.320B 0.00
Menlo Therapeutics (MNLO) United States $0.305B 0.00
Verastem (VSTM) United States $0.302B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.272B 0.00
Abeona Therapeutics (ABEO) United States $0.270B 0.00
Starpharma Holdings (SPHRY) Australia $0.268B 0.00
Aduro Biotech (ADRO) United States $0.263B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
Gritstone Oncology (GRTS) United States $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Exicure (XCUR) United States $0.241B 0.00
Liquidia Technologies (LQDA) United States $0.239B 0.00
XOMA (XOMA) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
OSMOTICA PHARM (OSMT) United States $0.230B 0.00
Northwest Biotherapeutics (NWBO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Affimed (AFMD) Germany $0.228B 0.00
HOOKIPA Pharma (HOOK) United States $0.224B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.215B 3.24
IVERIC Bio (ISEE) United States $0.213B 0.00
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
ARAVIVE, INC (ARAV) United States $0.204B 0.00
Kindred Biosciences (KIN) United States $0.201B 0.00
Strongbridge Biopharma (SBBP) United States $0.201B 0.00
Five Prime Therapeutics (FPRX) United States $0.199B 0.00
VTv Therapeutics (VTVT) United States $0.198B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.197B 0.00
Prometic Life Sciences (LMNL) Canada $0.195B 0.00
Aptinyx (APTX) United States $0.192B 0.00
Aytu Bioscience (AYTU) United States $0.182B 0.00
Dyadic (DYAI) United States $0.165B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.161B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.158B 0.00
Biofrontera AG (BFRA) Germany $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Antibe Therapeutics (ATBPF) Canada $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Trevena (TRVN) United States $0.144B 0.00
Cerecor (CERC) United States $0.142B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
AIT Therapeutics (XAIR) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.125B 0.00
Cyclerion Therapeutics (CYCN) United States $0.119B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
Eton Pharmaceuticals (ETON) United States $0.100B 0.00
Organovo Holdings (ONVO) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.091B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.089B 0.00
Celsion (CLSN) United States $0.089B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
Adocia (ADOCY) France $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Oncobiologics (OTLK) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Apricus Biosciences (SEEL) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.036B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
Evogene (EVGN) Israel $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
TrovaGene (CRDF) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00